# I08 — PYDANTIC_COMMON_CONTRACT — COMMON_TRANSCRIPT T2

## INPUT

Message utilisateur courant VERBATIM :

> Je préfère donc partir sur le T1 natif comme candidat principal, mais garder l'ECV exploratoire là où il est disponible.

Conversation précédente VERBATIM :

> I08:T0 | USER : Dans Fabry, on pense que le T1 natif pourrait être intéressant avant la fibrose, mais je n'ai pas décidé d'en faire le critère principal. À Lyon ils font aussi de l'ECV. Je veux surtout trouver un marqueur précoce qui soit utilisable dans tous les centres.
> I08:R1 | USER : Oui, tous les centres ont du T1 natif. Non, l'ECV seulement deux centres.

## NATIVE OUTPUT

Artefact : `experiments/semantic-engine-comparison/results/common-contract-ablation-02/native-outputs/common-transcript-i08-t2-pydantic-common-contract.json`

```json
{
  "firstOutput": {
    "ambiguities": [
      {
        "ambiguityId": "amb_ecv_feasibility",
        "content": "ECV availability and feasibility across all participating centers versus selected centers only",
        "decisionImpact": "Determines whether ECV can be the primary endpoint or must remain secondary/exploratory due to multicenter feasibility constraints.",
        "epistemicStatus": "AMBIGUOUS",
        "interpretations": [
          "ECV is only available in two centers, limiting its use to exploratory/secondary analysis.",
          "ECV might be expanded or standardized across all centers later (though currently stated as only in two centers)."
        ],
        "provenanceTurnIds": [
          "I08:T0",
          "I08:R1"
        ]
      }
    ],
    "clarificationCandidates": [
      {
        "blocking": false,
        "clarificationId": "clar_ecv_expansion",
        "decisionImpact": "Decides whether ECV can be integrated into secondary multicenter harmonization protocols or strictly kept to the two centers.",
        "priority": "LOW",
        "question": "Est-il envisageable d'harmoniser et d'étendre la mesure de l'ECV à d'autres centres que les deux actuels au cours de l'étude ?",
        "targetIds": [
          "amb_ecv_feasibility"
        ]
      }
    ],
    "contextualScientificCandidates": [],
    "contradictions": [],
    "conversationTurns": [
      {
        "content": "Dans Fabry, on pense que le T1 natif pourrait être intéressant avant la fibrose, mais je n'ai pas décidé d'en faire le critère principal. À Lyon ils font aussi de l'ECV. Je veux surtout trouver un marqueur précoce qui soit utilisable dans tous les centres.",
        "role": "USER",
        "turnId": "I08:T0"
      },
      {
        "content": "Oui, tous les centres ont du T1 natif. Non, l'ECV seulement deux centres.",
        "role": "USER",
        "turnId": "I08:R1"
      },
      {
        "content": "Je préfère donc partir sur le T1 natif comme candidat principal, mais garder l'ECV exploratoire là où il est disponible.",
        "role": "USER",
        "turnId": "I08:R2"
      }
    ],
    "correctionsAndSupersessions": [
      {
        "correctionId": "corr_primary_endpoint",
        "currentContent": "T1 natif is selected as the primary candidate marker.",
        "disposition": "SUPERSEDED",
        "previousContent": "T1 natif was considered interesting before fibrosis, but not yet decided as the primary criterion.",
        "provenanceTurnIds": [
          "I08:T0",
          "I08:R2"
        ]
      }
    ],
    "explicitUserStatements": [
      {
        "basis": null,
        "content": "Dans Fabry, on pense que le T1 natif pourrait être intéressant avant la fibrose, mais je n'ai pas décidé d'en faire le critère principal.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "stmt_t1_fabry_early",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I08:T0"
        ],
        "scientificRole": "phenomenon_and_biomarker",
        "sourceText": "Dans Fabry, on pense que le T1 natif pourrait être intéressant avant la fibrose, mais je n'ai pas décidé d'en faire le critère principal.",
        "temporalContext": "pre-fibrosis stage in Fabry disease"
      },
      {
        "basis": null,
        "content": "À Lyon ils font aussi de l'ECV.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "stmt_lyon_ecv",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I08:T0"
        ],
        "scientificRole": "method_or_measurement",
        "sourceText": "À Lyon ils font aussi de l'ECV.",
        "temporalContext": "current clinical practice"
      },
      {
        "basis": null,
        "content": "Je veux surtout trouver un marqueur précoce qui soit utilisable dans tous les centres.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "stmt_goal_multicenter",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I08:T0"
        ],
        "scientificRole": "project_requirement",
        "sourceText": "Je veux surtout trouver un marqueur précoce qui soit utilisable dans tous les centres.",
        "temporalContext": "study design phase"
      },
      {
        "basis": null,
        "content": "Oui, tous les centres ont du T1 natif.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "stmt_t1_all_centers",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I08:R1"
        ],
        "scientificRole": "project_variable",
        "sourceText": "Oui, tous les centres ont du T1 natif.",
        "temporalContext": "current study setup"
      },
      {
        "basis": null,
        "content": "Non, l'ECV seulement deux centres.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "stmt_ecv_two_centers",
        "ownership": "USER",
        "polarity": "NEGATED",
        "provenanceTurnIds": [
          "I08:R1"
        ],
        "scientificRole": "project_variable",
        "sourceText": "Non, l'ECV seulement deux centres.",
        "temporalContext": "current study setup"
      },
      {
        "basis": null,
        "content": "Je préfère donc partir sur le T1 natif comme candidat principal, mais garder l'ECV exploratoire là où il est disponible.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "stmt_decision_primary_t1",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I08:R2"
        ],
        "scientificRole": "endpoint_and_project_adoption",
        "sourceText": "Je préfère donc partir sur le T1 natif comme candidat principal, mais garder l'ECV exploratoire là où il est disponible.",
        "temporalContext": "final project decision phase"
      }
    ],
    "inferredContext": [],
    "missingInformation": [],
    "negationsAndConstraints": [
      {
        "basis": null,
        "content": "ECV is not available in all centers (restricted to two centers), precluding its use as the universal primary endpoint.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "neg_ecv_multicenter",
        "ownership": "USER",
        "polarity": "NEGATED",
        "provenanceTurnIds": [
          "I08:R1"
        ],
        "scientificRole": "constraint",
        "sourceText": "Non, l'ECV seulement deux centres.",
        "temporalContext": "current study setup"
      }
    ],
    "normalizedUnderstanding": "The user is designing a study in Fabry disease and aims to identify an early marker that is usable across all participating clinical centers. While native T1 is available in all centers, ECV is only available in two centers (including Lyon). Consequently, the user has decided to adopt native T1 as the primary candidate marker/endpoint, while retaining ECV as an exploratory measurement where available.",
    "objects": [
      {
        "basis": null,
        "content": "T1 natif",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "obj_native_t1",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I08:T0",
          "I08:R1",
          "I08:R2"
        ],
        "scientificRole": "biomarker_and_endpoint",
        "sourceText": "T1 natif",
        "temporalContext": "study duration"
      },
      {
        "basis": null,
        "content": "ECV",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "obj_ecv",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I08:T0",
          "I08:R1",
          "I08:R2"
        ],
        "scientificRole": "exploratory_biomarker",
        "sourceText": "ECV",
        "temporalContext": "study duration"
      }
    ],
    "originalRequest": "Dans Fabry, on pense que le T1 natif pourrait être intéressant avant la fibrose, mais je n'ai pas décidé d'en faire le critère principal. À Lyon ils font aussi de l'ECV. Je veux surtout trouver un marqueur précoce qui soit utilisable dans tous les centres.",
    "ownershipAndEpistemicState": [
      {
        "content": "T1 natif is chosen as the primary candidate marker for Fabry disease because it is available across all centers.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "owner": "USER",
        "provenanceTurnIds": [],
        "statementId": "state_primary_t1"
      },
      {
        "content": "ECV is kept as an exploratory marker in centers where it is available (two centers).",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "owner": "USER",
        "provenanceTurnIds": [],
        "statementId": "state_ecv_exploratory"
      }
    ],
    "relations": [
      {
        "basis": null,
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "object": "obj_native_t1",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "predicate": "is_adopted_as_primary_endpoint_for",
        "provenanceTurnIds": [
          "I08:R2"
        ],
        "relationId": "rel_primary_endpoint_t1",
        "sourceText": "Je préfère donc partir sur le T1 natif comme candidat principal",
        "subject": "USER",
        "temporalContext": "study design"
      },
      {
        "basis": null,
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "object": "obj_ecv",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "predicate": "is_kept_as_exploratory_marker_in",
        "provenanceTurnIds": [
          "I08:R2"
        ],
        "relationId": "rel_exploratory_ecv",
        "sourceText": "garder l'ECV exploratoire là où il est disponible",
        "subject": "USER",
        "temporalContext": "study design"
      },
      {
        "basis": null,
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "object": "stmt_t1_all_centers",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "predicate": "motivates_selection_of",
        "provenanceTurnIds": [
          "I08:R1",
          "I08:R2"
        ],
        "relationId": "rel_t1_multicenter_motivation",
        "sourceText": "Je veux surtout trouver un marqueur précoce qui soit utilisable dans tous les centres. Oui, tous les centres ont du T1 natif. Je préfère donc partir sur le T1 natif comme candidat principal",
        "subject": "obj_native_t1",
        "temporalContext": "study design"
      }
    ],
    "scientificGoal": "Identify an early biomarker in Fabry disease usable across all participating centers, establishing native T1 as the primary endpoint and ECV as an exploratory endpoint.",
    "temporalModel": [],
    "unknowns": []
  }
}
```

## STRUCTURED CONTRACT STATUS

- provider status : `SUCCESS`
- parsing status : `PARSED_AND_VALIDATED`
- structured contract conformance : `PASS`
- scientific semantic evaluability : `EVALUABLE`
- evaluation mode : `DETERMINISTIC_COMMON_STATE_PROJECTION`
- native raw output persisted : `false`

## SCIENTIFIC INTERPRETATION

### COMPRÉHENSION GLOBALE

The user is designing a study in Fabry disease and aims to identify an early marker that is usable across all participating clinical centers. While native T1 is available in all centers, ECV is only available in two centers (including Lyon). Consequently, the user has decided to adopt native T1 as the primary candidate marker/endpoint, while retaining ECV as an exploratory measurement where available.

Objectif scientifique produit :

Identify an early biomarker in Fabry disease usable across all participating centers, establishing native T1 as the primary endpoint and ECV as an exploratory endpoint.

### EXPLICITEMENT DIT PAR LE CHERCHEUR

- content=Dans Fabry, on pense que le T1 natif pourrait être intéressant avant la fibrose, mais je n'ai pas décidé d'en faire le critère principal. | scientificRole=phenomenon_and_biomarker | polarity=AFFIRMED | temporalContext=pre-fibrosis stage in Fabry disease | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | sourceText=Dans Fabry, on pense que le T1 natif pourrait être intéressant avant la fibrose, mais je n'ai pas décidé d'en faire le critère principal. | provenanceTurnIds=["I08:T0"]
- content=À Lyon ils font aussi de l'ECV. | scientificRole=method_or_measurement | polarity=AFFIRMED | temporalContext=current clinical practice | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | sourceText=À Lyon ils font aussi de l'ECV. | provenanceTurnIds=["I08:T0"]
- content=Je veux surtout trouver un marqueur précoce qui soit utilisable dans tous les centres. | scientificRole=project_requirement | polarity=AFFIRMED | temporalContext=study design phase | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | sourceText=Je veux surtout trouver un marqueur précoce qui soit utilisable dans tous les centres. | provenanceTurnIds=["I08:T0"]
- content=Oui, tous les centres ont du T1 natif. | scientificRole=project_variable | polarity=AFFIRMED | temporalContext=current study setup | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | sourceText=Oui, tous les centres ont du T1 natif. | provenanceTurnIds=["I08:R1"]
- content=Non, l'ECV seulement deux centres. | scientificRole=project_variable | polarity=NEGATED | temporalContext=current study setup | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | sourceText=Non, l'ECV seulement deux centres. | provenanceTurnIds=["I08:R1"]
- content=Je préfère donc partir sur le T1 natif comme candidat principal, mais garder l'ECV exploratoire là où il est disponible. | scientificRole=endpoint_and_project_adoption | polarity=AFFIRMED | temporalContext=final project decision phase | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | sourceText=Je préfère donc partir sur le T1 natif comme candidat principal, mais garder l'ECV exploratoire là où il est disponible. | provenanceTurnIds=["I08:R2"]

### RELATIONS COMPRISES

- subject=USER | predicate=is_adopted_as_primary_endpoint_for | object=obj_native_t1 | polarity=AFFIRMED | temporalContext=study design | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | sourceText=Je préfère donc partir sur le T1 natif comme candidat principal | provenanceTurnIds=["I08:R2"]
- subject=USER | predicate=is_kept_as_exploratory_marker_in | object=obj_ecv | polarity=AFFIRMED | temporalContext=study design | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | sourceText=garder l'ECV exploratoire là où il est disponible | provenanceTurnIds=["I08:R2"]
- subject=obj_native_t1 | predicate=motivates_selection_of | object=stmt_t1_all_centers | polarity=AFFIRMED | temporalContext=study design | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | sourceText=Je veux surtout trouver un marqueur précoce qui soit utilisable dans tous les centres. Oui, tous les centres ont du T1 natif. Je préfère donc partir sur le T1 natif comme candidat principal | provenanceTurnIds=["I08:R1", "I08:R2"]

### CONTEXTE INFÉRÉ

- Aucun élément produit.

### CANDIDATS SCIENTIFIQUES CONTEXTUELS

- Aucun élément produit.

### NÉGATIONS / CONTRAINTES

- content=ECV is not available in all centers (restricted to two centers), precluding its use as the universal primary endpoint. | scientificRole=constraint | polarity=NEGATED | temporalContext=current study setup | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | sourceText=Non, l'ECV seulement deux centres. | provenanceTurnIds=["I08:R1"]

### TEMPORALITÉ

- Aucun élément produit.

### AMBIGUÏTÉS

- content=ECV availability and feasibility across all participating centers versus selected centers only | epistemicStatus=AMBIGUOUS | decisionImpact=Determines whether ECV can be the primary endpoint or must remain secondary/exploratory due to multicenter feasibility constraints. | provenanceTurnIds=["I08:T0", "I08:R1"] | interpretations=["ECV is only available in two centers, limiting its use to exploratory/secondary analysis.", "ECV might be expanded or standardized across all centers later (though currently stated as only in two centers)."]

### INFORMATIONS MANQUANTES

- Aucun élément produit.

### INCONNUES

- Aucun élément produit.

### CORRECTIONS / SUPERSESSIONS

- previousContent=T1 natif was considered interesting before fibrosis, but not yet decided as the primary criterion. | currentContent=T1 natif is selected as the primary candidate marker. | provenanceTurnIds=["I08:T0", "I08:R2"] | disposition=SUPERSEDED

### OWNERSHIP / STATUT ÉPISTÉMIQUE

- content=T1 natif is chosen as the primary candidate marker for Fabry disease because it is available across all centers. | epistemicStatus=EXPLICIT_USER_STATED | owner=USER
- content=ECV is kept as an exploratory marker in centers where it is available (two centers). | epistemicStatus=EXPLICIT_USER_STATED | owner=USER

### QUESTIONS DE CLARIFICATION CANDIDATES

- question=Est-il envisageable d'harmoniser et d'étendre la mesure de l'ECV à d'autres centres que les deux actuels au cours de l'étude ? | priority=LOW | blocking=non | decisionImpact=Decides whether ECV can be integrated into secondary multicenter harmonization protocols or strictly kept to the two centers. | targetIds=["amb_ecv_feasibility"]

## MISSING STRUCTURAL GUARANTEES

- EXACT_PROVIDER_RAW_TEXT_NOT_PERSISTED; STRUCTURED_NATIVE_ARTIFACT_AVAILABLE

_Vue locale déterministe. Aucun appel LLM d’interprétation sémantique post-hoc._
